Abstract
An expression cassette containing kringle 2 and serine protease domains (K2S), tissue plasminogen activator (tPA), together with a signal sequence derived from Leishmania tarentolae and two fragments of the small subunit ribosomal RNA locus, was introduced into L. tarentolae. The transfected cells produced recombinant K2S (rK2S) protein extracellularly with serine protease activity. Expression and enzyme activity of rK2S in the supernatant was 930 i.u./ml. The specific activity of purified rK2S was 7.4 U/mg of protein. Replacement of the human signal sequence tPA with the signal sequence derived from Leishmania increased the secretion of recombinant protein up to 30 times.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Tissue plasminogen activator (tPA) is a serine protease containing 527 amino acid residues with a molecular mass of 72 kDa (Pennica et al. 1983). The finger domain (F), the epidermal growth factor domain (EGF), two kringle domains (K1 and K2), and the C-terminal serine protease domain (S) are five functional domains of this protein. tPA is a fibrin-specific plasminogen activator (Rouf et al. 1996) with no risk of extensive fibrinogen depletion and concomitant bleeding risks (Ellis and Brener 2004). tPA is thus a superior thrombolytic agent for treating acute myocardial infarction and pulmonary embolism but its clinical efficiency and pharmacokinetic properties should be improved (Baruah et al. 2006). Kringle 2 and serine protease domains (K2S) is a 39 kDa derivative of tPA with K2S (Mattes 2001). The hepatic clearance of K2S is reduced and its plasma half-life is increased to 14–18 min (versus 3–4 min with native tPA) (Nordt and Bode 2003). Insertion of K2S sequence into Escherichia coli leads to the formation of inactive inclusion bodies that must be purified and refolded to achieve activity (Kohnert et al. 1992). In recent years, scientists have recognized some members of the trypanosomatidae family, as new systems for the production of heterologous protein (Clayton 2002; Georgiou and Valax 1996; Hockney 1994; Orlando et al. 2007). Leishmania tarentolae is a non-pathogenic lizard-infecting example (Orlando et al. 2007).
The aim of this study was to introduce an expression cassette containing K2S form of tPA into the small subunit ribosomal (ssu) locus of 18s rRNA genes of L. tarentolae. In addition, we evaluated whether transfected Leishmania could produce recombinant K2S (rK2s) protein in active form.
Materials and methods
Amplification and cloning of K2S gene
The K2S fragment of tPA gene was amplified by PCR using pTZ57R-tPA plasmid as a template (Gift) with forward primer, F-K2S (5′-ACAGGCGCCTCTTACCAAGGAAACAGTGACTGCTAC-3′) containing a KasI site, 1–3 amino acids codon sequence and reverse primer, and R-K2S (5′-ACACTCGAGTCACACCACCACCACCACCACCGGTCGCATGTTGTCACG-3′) containing a XhoI site and a stop codon. Primers were designed on the basis of the human tPA gene sequence (GenBank accession number 101047). An Eppendorf DNA thermal cycler and Expand Long Template PCR System were used for amplification of the desired fragment in 30 cycles of denaturation for 1 min at 94°C, annealing for 1 min at 68°C and extension for 1 min at 72°C, followed by 72°C for 10 min as a final extension. The PCR product was cloned in pGEM-T Easy vector (T-A cloning, Promega Co) using manufacturer’s procedures yielding the recombinant plasmid pGEM-T vector-K2S. The recombinant plasmids were confirmed by digestion analysis with KasI and XhoI restriction enzymes and sequencing using M13 forward and reverse primers. The insert was removed by KasI and XhoI digestion and cloned into the KasI–XhoI insertion site of Leishmania expression vector pF4splmsapx1.4hyg (Jena Bioscience, Jena, Germany) to create the recombinant pF4splmsapx1.4hyg plasmid. The presence of the K2S gene in pF4splmsapx1.4hyg-K2S plasmid was confirmed by KasI and XhoI restriction enzymes.
Transfection and cultivation of L. tarentolae
L. tarentolae was cultivated in brain–heart infusion (BHI) broth medium supplemented with 5 μg of hemin/ml at 26°C. Transfection was carried out by electroporation of in vitro cultivated promastigotes at 108 cells/ml. Recombinant clones were selected as single colonies on solidified BHI medium containing 50 μg hygromycin B/ml (Sigma) as selective antibiotic. For electroporation, ~10 μg of the expression plasmid was digested with SwaI for linearization and integration into the ssu locus. Integration of the expression cassette into the ssu locus of 18s rRNA was confirmed by PCR on genomic DNA with hyg (hygromycin resistance) forward primer 5′-CATGAAAAAGCCTGAACTCACCGCG-3′ and reverse ssu primer 5′-CTGCAGGTTCACCTACAGCTAC-3′.
Purification and evaluation of the expression of recombinant protein with western blotting
Recombinant protein was expressed as a secretory hexa-histidine-tag fusion protein in the supernatant of transformed L. tarentolae culture. Recombinant protein containing the histidine tag was affinity purified using Ni–NTA resin (Qiagen) according to the manufacturer’s protocol with some modifications. Briefly, the supernatant was passed through a FPLC column containing 15 ml Ni–NTA resin, washed with buffer A containing 20 mM imidazole, 300 mM NaCl, and 50 mM sodium phosphate buffer followed by elution of the bound material with linear gradient buffer B (2–100%) containing 300 mM imidazole, 300 mM NaCl and 50 mM sodium phosphate buffer at 60 min. The purified recombinant protein was shown by SDS-PAGE analysis to be free of any significant amount of Leishmania protein. For western blotting, 30–35 μg culture supernatant of transformed cell or 5 μg purified rK2S was separated on 12% (v/v) SDS-PAGE gel and blotted onto a nitrocellulose membrane. The membrane was blocked 2 h at room temperature with 5% (v/v) skim milk in PBS containing 0.05% Tween 20 and incubated for 2 h with 1/1,000 dilution of rabbit anti-tPA antibodies (Abcam). After washing, the membrane was incubated in a 1/3,000 dilution of horse radish peroxidase conjugated goat anti-rabbit IgG (Abcam). Then, reactive bands were detected by peroxidase/3.3′ diaminobenzidine substrate.
Zymography
Zymography analysis was performed for assay of the plasminogenolytic activity of rK2S protein. The SDS-PAGE gels were copolymerized with plasminogen (Chromogenix, Milan, Italy) and gelatin as sequential substrates for detecting proteolytic bands. After electrophoresis at 4°C at a constant current of 8 mA, the gels were washed with 2.5% Triton X-100 for 1 h with shaking at room temperature (25°C) to remove the SDS. The gels were then incubated in 0.1 M glycine/NaOH (pH 8.3) for 5 h at 37°C. Finally, the gels were stained and destained using Coomassie Brilliant Blue R-250. The location of the peptide possessing enzymatic activity was revealed as clear zone on a blue background.
Determination of amidolytic activity
Biopool’s Chromolize tPA assay kit was used to determine the amidolytic activity of rK2S. [Chromolize tPA is a bio-functional immunosorbent assay intended for the quantitative determination of human tPA.] The assay started by adding the samples to the microtest wells which contains antibodies. The wells were washed with mild detergent and the sample was captured by antibodies on the microtest wells. The substrate consisting of plasminogen and a plasmin-sensitive chromogenic substrate was added. The amidolytic activity was calculated from the increase of absorbance at 405 nm.
Results
Cloning of K2S gene
The K2S gene was amplified by PCR using forward and reverse primers and a single 1100 bp band was seen on agarose gel after electrophoresis. The K2S gene was cloned into the KasI/XhoI site of expression vector (Fig. 1), containing signal sequence derived from the secreted acid phosphatase of Leishmania mexicana and the antibiotic resistance gene (Fig. 2A). Then expression cassette containing K2S gene was flanked by two fragments of the small subunit rRNA locus (5′ssu and 3′ssu) for double homologous recombination and was introduced into L. tarentolae by electroporation. The integration of the expression cassette into the ssu locus was confirmed by diagnostic PCR. For this purpose, primer pairs, including on primer hybridizing within the expression cassette (hyg forward primer), and one primer hybridizing to ssu sequence (ssu reverse primer) which is not present on the plasmid were used. The expected 2.8 kb band was only observed from transformed cells indicating the proper integration of expression cassette into the ssu locus in the genomic DNA. The desired band was not obtained in control reactions where the template was the genomic DNA from the wild type cells (Fig. 2B).
Expression of rK2S protein in L. tarentolae
Purification of recombinant protein was performed by affinity chromatography and fractions were analyzed by SDS-PAGE (Fig. 3A). A desired band was at 40 kDa, which is slightly higher than the native mature protein due to the addition of a hexa-his-tag sequence. The presence of rK2S in the culture supernatants and in the fractions of purification was determined by western blotting (Fig. 3B).
The sharp clear zones on the blue background of the zymography gel indicated the activity of rK2S serine protease which observed only in the culture supernatant of transformed L. tarentolae (Fig. 4).
The culture supernatant of transformed L. tarentolae with secretory expression vector pF4splmsapx1.4hyg containing K2S gene, showed an enzymatic activity of 931 i.u./ml. The specific activity of purified rK2S was calculated as 7.43 U/mg of protein.
Discussion
The K2S gene was cloned into a vector for high level protein expression by integration of the expression cassettes into the ssu rRNA gene of L. tarentolae, which is strongly transcribed by RNA polymerase I (Misslitz et al. 2000). Western blotting analysis by using a rabbit anti-tPA antibodies showed that transfected Leishmania produce rK2S protein extracellularly in supernatant culture medium; but this protein was absent in supernatant culture of untransfected cells. Our study showed serine protease activity of the produced rK2S. We tested it according to Heussen and Dowdle (1980) demonstrating that plasminogen-independent proteases could be detected and analyzed by omitting plasminogen from the zymography gel.
Manosroi et al. (2001) produced rK2S in E. coli with an activity of 7 i.u./ml. The enzyme activity for rK2S produced in transfected L. tarentolae was 931 i.u./ml. To evaluate the efficiency of the signal sequence we replaced the native signal sequence of human tPA with the signal sequence derived from secreted acid phosphatase of L. mexicana. Soleimani et al. (2007) used the native human signal sequence of tPA gene for cloning this gene in L. tarentolae and reported an enzyme activity of 30 i.u./ml. Our findings were consistent with the observation of Breitling et al. (2002) that replacement of the native human signal sequence with the signal sequence derived from Leishmania increased considerably secretion of recombinant protein.
In the current study, deletion of the three N-terminal domains did not have any influence on the active site of the serine protease domain and the biological activity properties of the kringle 2 and protease domains. These data were in accordance with the findings of Manosroi et al. (2001), too.
On the other hand, we showed that L. tarentolae can be utilized for significant production of rK2S; the recombinant human K2S protein produced in L. tarentolae cells shows normal biological activity and proper folding. The Leishmania expression system has also been successfully used to produce many other proteins including active mammalian cytokines such as IL-2 and IFN-gamma in previous studies (La Flamme et al. 1995; Tobin et al. 1993; Breitling et al. 2002).
References
Baruah DB, Dash RN, Chaudhari MR et al (2006) Plasminogen activators: a comparison. Vascul Pharmacol 44:1–9
Breitling R, Klingner S, Callewaert N et al (2002) Non-pathogenic trypanosomatid protozoa as a platform for protein research and production. Protein Expr Purif 25:209–218
Clayton CE (2002) Life without transcriptional control? From fly to man and back again. EMBO J 21:1881–1888
Ellis K, Brener S (2004) New fibrinolytic agents for MI: as effective as current agents, but easier to administer. Clevel Clin J Med 71(20):23–25 29–30 passim
Georgiou G, Valax P (1996) Expression of correctly folded proteins in Escherichia coli. Curr Opin Biotechnol 7:190–197
Heussen C, Dowdle EB (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102:196–202
Hockney RC (1994) Recent developments in heterologous protein production in Escherichia coli. Trends Biotechnol 12:456–463
Kohnert U, Rudolph R, Verheijen JH et al (1992) Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022. Protein Eng 5:93–100
La Flamme AC, Buckner FS, Swindle J et al (1995) Expression of mammalian cytokines by Trypanosoma cruzi indicates unique signal sequence requirements and processing. Mol Biochem Parasitol 75:25–31
Manosroi J, Tayapiwatana C, Götz F et al (2001) Secretion of active recombinant human tissue plasminogen activator derivatives in Escherichia coli. Appl Environ Microbiol 67:2657–2664
Mattes R (2001) The production of improved tissue-type plasminogen activator in Escherichia coli. Semin Thromb Hemost 27:325–336
Misslitz A, Mottram JC, Overath P et al (2000) Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes. Mol Biochem Parasitol 107:251–261
Nordt TK, Bode C (2003) Thrombolysis: newer thrombolytic agents and their role in clinical medicine. Heart 89:1358–1362
Orlando TC, Mayer MG, Campbell DA et al (2007) RNA polymerase I promoter and splice acceptor site recognition affect gene expression in non-pathogenic Leishmania species. Mem Inst Oswaldo Cruz 102:891–894
Pennica D, Holmes WE, Kohr WJ et al (1983) Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 301:214–221
Rouf SA, Moo-Young M, Chisti Y (1996) Tissue-type plasminogen activator: characteristics, applications and production technology. Biotechnol Adv 14:239–266
Soleimani M, Mahboudi F, Davoudi N et al (2007) Expression of human tissue plasminogen activator in the trypanosomatid protozoan Leishmania arentolae. Biotechnol Appl Biochem 48:55–61
Tobin JF, Reiner SL, Hatam F et al (1993) Transfected Leishmania expressing biologically active IFN-gamma. J Immunol 150:5059–5069
Acknowledgment
This work was supported by a grant from the Pasteur Institute of Iran.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nazari, R., Davoudi, N. Cloning and expression of truncated form of tissue plasminogen activator in Leishmania tarentolae . Biotechnol Lett 33, 503–508 (2011). https://doi.org/10.1007/s10529-010-0470-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-010-0470-y